Wrazliwosc in vitro i in vivo Streptococcus suis na ceftiofur

• Autorzy: Jablonski A , Lesiak M. , Porowski M. , Wojciechowski J. , Stepnicki A. , Pejsak Z.

Warianty tytułu

EN

In vitro and in vivo susceptibility to ceftiofur of Streptococcus suis

• Języki publikacji: PL

Abstrakty

EN

The aim of the study was to determine ceftiofur sensitivity of Streptococcus suis isolated from pathologically altered brains and joints of pigs with streptococci compared with the efficacy of treating two diverse forms of Streptococci infections in pigs (neurological and joint infections) with the same antibiotic depending on the severity of the clinical signs. The study was carried out on two farms - “P” and “W”. The results of the in vitro study demonstrated that 98.5% of the 67 Streptococcus suis isolates were sensitive to ceftiofur. Only one isolate from the joint was medium sensitive. The efficacy of the treatment (in vivo studies) in stage I of both the neurological form (apathy, auricular symptoms) and articular form (lameness, lack of evident swelling or mild swelling of one joint) of streptococcal disease proved to be significantly high on the farms (between 90.3-100%). The efficacy of treating more severe cases was lower and the course treatment was also longer. The proportion of recoveries in the neurological form (increase of body temperature above 41.0°C and in coordination) of streptococcal infections ranged from 66.7% on farm “W” to 72.8% on farm “P”. The results obtained in analogous groups of animals with moderately severe joint infections (lameness and evident swelling of one joint) ranged from 47.7% on farm “W” to 56.4% on farm “P”. The proportion of the recovered animals affected with neurological symptoms of stage III (lateral position, rowing movements) was 44.4% on “P” farm and merely 28.6% on farm “W”. A positive outcome of polyarthritis treatment during the three week observation period was noted in 10.7% of the cases on farm “P” and in only one weaner (4.5%) on farm “W”. Treatment failures of the articular form of streptococcal infections compared to the neurological form were not estimated in terms of losses but rather as chronic inflammations persisting beyond the observation period and requiring further therapeutic procedures or, more frequently, culling of the animals. It may be concluded that ceftiofur is characterized by its significant efficacy in treating clinical symptoms which have been diagnosed early and cured. The in vivo studies, where there was an intensification of the disease data, indicated the antibiotic’s efficacy and good penetration into joints and cerebrospinal fluid during inflammation. Speed in diagnosing and treating an ongoing S.suis infection plays a critical role in the efficacy of the therapy.

Słowa kluczowe

PL

streptokokoza; badania in vivo; trzoda chlewna; skutecznosc; ceftiofur; choroby zwierzat; wrazliwosc na antybiotyki; badania in vitro; Streptococcus suis

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 02
• Opis fizyczny: s.228-231,rys.,fot.,bibliogr.

Twórcy

autor

Jablonski A

• Panstwowy Instytut Weterynaryjny-Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Lesiak M.

autor

Porowski M.

autor

Wojciechowski J.

autor

Stepnicki A.

autor

Pejsak Z.

Bibliografia

• 1. Abraham E. P.: Cephalosporins 1945-1986. Drugs 1987, 34, 1-14.
• 2. Anon.: NCCLS Draft: Perfomance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals; Approved Standard Second Edition, Wayne 2001, 19, 11.
• 3. Beconi-Barker M. G., Hornish R. E., Vidmar T. J., Dame K. J., Brown S. A.: Ceftiofur hydrochloride: plasma and tissue distribution in swine following intramuscular administration at various doses. J. Vet. Pharmacol. Ther. 1996, 19, 192-199.
• 4. Burton P. J., Thornsberry C., Cheung Yee Y., Watts J. L., Yancey R. J.: Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease. J. Vet. Diagn. Invest. 1996, 8, 464-468.
• 5. Chanel G. G., Hoban D. J., Harding K.: The antibiotic effect: a review of in vitro and in vivo data. Drug Intel.&Clin. Ph. 1991, 25, 153-163.
• 6. Chanter N., Jones P. W., Alexander T. J.: Meningitis in pigs caused by Streptococcus suis a speculative review. Vet. Microbiol. 1993, 36, 39-55.
• 7. Cheng A. F., Oo K. T., Li E. K., French G. L.: Septic arthritis caused by Streptococcus suis serotype 2. J. Infect. 1987, 14, 237-241.
• 8. Crane J. P., Portis E. S., Lindeman C. J., Salomon S. A., Case C. A.: Minimum inhibitory concentration determinations for ceftiofur against swine pathogens from United States and Canada in 2001-2002. Proc. 18th Internat. Pig Veterinary Society Congress, Hamburg 2004, s. 534.
• 9. Gronowski J.: Patomorfologia. PZWL, Warszawa 1981.
• 10. Kania B. F.: Chemioterapia weterynaryjna. Wyd. Fundacja Rozwój SGGW, Warszawa 1997.
• 11. Katsumi M., Kataoka Y., Takahashi T., Kikuchi N., Hiramune T.: Bacterial isolation from slaughtered pigs associated with endocarditis, especially the isolation of Streptococcus suis. J. Vet. Med. Sci. 1997, 59, 75-78.
• 12. Madsen L. W., Svensmark B., Elvestad K., Aalbaek B., Jensen H. E.: Streptococcus suis serotype 2 infection in pigs: new diagnostic and pathogenetic aspects. J. Comp. Pathol. 2002, 126, 57-65.
• 13. Pejsak Z., Jabłoński A., Żmudzki J.: Lekowrażliwość bakterii chorobotwórczych układu oddechowego świń. Medycyna Wet. 2005, 61, 664-668.
• 14. Pejsak Z., Tarasiuk K., Sadoch L.: Nagłe zachorowania i padnięcia warchlaków i tuczników na tle zakażeń Streptococcus suis typ 2. Medycyna Wet. 2001, 57, 251-254.
• 15. Reams R. Y., Glickman L. T., Harrington D. D., Thacker H. L., Bowersock T. L.: Streptococcus suis infection in swine: a retrospective study of 256 cases. Part II. Clinical signs, gross and microscopic lesions, and coexisting microorganisms. J. Vet. Diagn. Invest. 1994, 6, 326-334.
• 16. Singh P. K., Parsek M. R., Greenberg E. P., Welsh M. J.: A component of innate immunity prevents bacterial biofilm development. Nature 2002, 417, 552-555.
• 17. Stewart P. S.: Diffusion in biofilms. J. Bacteriol. 2003, 185, 1485-1491.
• 18. Williams A. E., Blakemore W. F.: Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 1990, 162, 474-481.